Rezultati pretrage - Jean Viallet

  • Prikaz rezultata 1 – 13 od 13
Detaljiziraj rezultate
  1. 1
    The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies

    The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies od Paul Garcia, Yan Wang, Jean Viallet, Zuzana Macek Jílková

    Izdano 2021
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2

    Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2 od Auriane Kroiss, S. Vincent, Myriam Decaussin‐Petrucci, Emmanuelle Meugnier, Jean Viallet, A. Ruffion, Frédéric Chalmel, Jacques Samarut, Nathalie Allioli

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia

    Phase I study of obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia od Susan O’Brien, David F. Claxton, Michael Crump, Stefan Faderl, Thomas J. Kipps, Michael J. Keating, Jean Viallet, Bruce D. Cheson

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.

    Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. od Martha H. Corjay, David Dobrzanski, James M. Way, Jean Viallet, Hagit Shapira, Peter J. Worland, Edward A. Sausville, J.F. Battey

    Izdano 1991
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells.

    BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. od Zahra Fathi, Martha H. Corjay, Hagit Shapira, Etsuko Wada, Richard V. Benya, Robert T. Jensen, Jean Viallet, E. A. Sausville, James F. Battey

    Izdano 1993
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Anti-Metastatic and Anti-Tumor Growth Effects of Origanum majorana on Highly Metastatic Human Breast Cancer Cells: Inhibition of NFκB Signaling and Reduction of Nitric Oxide Production

    Anti-Metastatic and Anti-Tumor Growth Effects of Origanum majorana on Highly Metastatic Human Breast Cancer Cells: Inhibition of NFκB Signaling and Reduction of Nitric Oxide Produc... od Yusra Al Dhaheri, Samir Attoub, Kholoud Arafat, Synan F. AbuQamar, Jean Viallet, Alaaeldin Saleh, Hala Al Agha, Ali H. Eid, Rabah Iratni

    Izdano 2013
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma

    Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma od Jimmy J. Hwang, John Kuruvilla, David S. Mendelson, Michael J. Pishvaian, John F. Deeken, Lillian L. Siu, Mark S. Berger, Jean Viallet, John L. Marshall

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism

    Genetic and Pharmacologic Inhibition of mTORC1 Promotes EMT by a TGF-β–Independent Mechanism od Ivan Mikaélian, Mouhannad Malek, Rudy Gadet, Jean Viallet, Amandine Garcia, Anaïs Girard-Gagnepain, Cédric Hesling, Germain Gillet, Philippe Gonzalo, Ruth Rimokh, Marc Billaud

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax)

    Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax) od Marina Konopleva, Julie C. Watt, Rooha Contractor, Twee Tsao, David Harris, Zeev Estrov, William G. Bornmann, Hagop Kantarjian, Jean Viallet, Ismael Samudio, Michael Andreeff

    Izdano 2008
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy

    The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophag... od Yue Wei, Tapan M. Kadia, Weigang Tong, Ming Zhang, Yu Jia, Hui Yang, Yumin Hu, Francesco Paolo Tambaro, Jean Viallet, Susan O’Brien, Guillermo Garcia-Manero

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    The CAM Model—Q&A with Experts

    The CAM Model—Q&A with Experts od Dagmar Fischer, Georg Fluegen, Paul Garcia, Nassim Ghaffari‐Tabrizi‐Wizsy, Laura Gribaldo, Ruby Yun‐Ju Huang, Volker Rasche, Doménico Ribatti, Xavier Rousset, Marta Pinto, Jean Viallet, Yan Wang, Regine Schneider‐Stock

    Izdano 2022
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  12. 12
    Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

    Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis od Mai Nguyen, Richard Marcellus, Anne Roulston, Mark Watson, Lucile Serfass, S.R. Murthy Madiraju, Daniel Goulet, Jean Viallet, Laurent Bélec, Xavier Billot, Stéphane Acoca, Enrico O. Purisima, Adrian P. Wiegmans, Leonie A. Cluse, Ricky W. Johnstone, Pierre Beauparlant, Gordon C. Shore

    Izdano 2007
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies od Aaron D. Schimmer, Susan O’Brien, Hagop M. Kantarjian, Joseph Brandwein, Bruce D. Cheson, Mark D. Minden, Karen Yee, Farhad Ravandi, Francis J. Giles, Andre C. Schuh, Vikas Gupta, Michael Andreeff, Charles Koller, Hong Chang, Suzanne Kamel‐Reid, Mark S. Berger, Jean Viallet, Gautam Borthakur

    Izdano 2008
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: